(2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Zhao, Biosensors and Bioelectronics 94, (2017) 523529
9 Some secondary and cosmetic-science sources assert that GHK-Cu activates Wnt/-catenin in dermal papilla cells
Decades of research studied extensively for telomerase and longevity effects Telomere-focused targets cellular aging at the chromosomal level Favorable safety profile minimal side effects in clinical studies Medical supervision requires physician oversight for optimal protocols Speak With a Physician 10-20 days Typical treatment cycle duration for Epithalon protocols Daily Standard dosing frequency during active treatment cycles Epithalon is unique in its specific mechanism of actiontelomerase activation
This precision approach means your injection site strategy is tailored to your biology, not a one-size-fits-all recommendation